How Estrogen Influences SLE Across a Woman’s Lifespan – The Lupus Foundation of Australasia
The Lupus Foundation of Australasia shared a post on LinkedIn:
“Oestrogen and Lupus: Why It Matters
Systemic lupus erythematosus (SLE) is the most common form of lupus, and affects women at significantly higher rates. SLE affects many women, and changes in oestrogen levels can influence symptoms and flare-ups at different life stages.
From adolescence through to menopause, fluctuations in oestrogen can influence immune response, symptom severity, and flare risk.
Building awareness of these patterns is essential to improving patient education, supporting informed care, and strengthening outcomes for women living with lupus.
Click on the link below to learn more.
Disclaimer:
At THE LUPUS FOUNDATION OF AUSTRALASIA, our mission is to raise awareness and support patients with evidence-based information.
This content is intended for general informational purposes only and does not constitute medical advice. Individuals should consult a qualified healthcare professional before commencing any new exercise or treatment program, particularly those living with lupus.”
Alannah Hibbard, Medical Receptionist at Guardian Medical Pty Ltd, shared THE LUPUS FOUNDATION OF AUSTRALASIA’s post, adding:
“Excited to share that I have recently joined the Lupus Foundation of Australasia as a volunteer medical writer.
This May marked both World Lupus Day and Mother’s Day in Australia. It is an important reminder that lupus predominantly affects women and disease activity can change throughout puberty, pregnancy, and menopause. My first article explores this and unpacks how oestrogen influences lupus activity across the female lifespan.
Through this role I hope to contribute to patient education and advocacy, as well as raise awareness for a rare but debilitating disease. A huge thank you to the Lupus Foundation for this opportunity.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 21, 2026, 12:26Thrombotic Recurrence After Stopping Anticoagulation in APS – JTH
-
May 21, 2026, 12:21Did You Know You Can Actively Contribute to ESHRE Guidelines? – ESHRE
-
May 21, 2026, 12:19Effect of Adenomyosis on the Cumulative Live Birth Rate in Oocyte Donation Cycles – RBMO
-
May 21, 2026, 12:17Christopher Robinson: Diagnosis of Placenta Accreta Spectrum by the ‘Rail’ and ‘Tramline’ Signs
-
May 21, 2026, 12:13Biochemical Pregnancy in IVF, Why Chromosomes Aren’t the Whole Story? – Fertility Plus
-
May 21, 2026, 12:11Are You Curious About How the New Obstetric Codes Will Affect Your Practice? – ACOG
-
May 20, 2026, 10:04ACOG’s Rate Navigator Report is Officially Live – ACOG
-
May 20, 2026, 10:01Efficacy and Safety of a One-Step Warming Protocol of Vitrified Blastocysts – Fertility and Sterility
-
May 20, 2026, 09:36Pelvic Pain and Endometriosis Featured in ISUOG World Congress 2026 Programme – ISUOG